Table 2 Prevalence and density of P. vivax at baseline and endpoint
| Â | Baseline | Endpoint | p value | OR/GMR (95%CI) |
|---|---|---|---|---|
Parasite prevalence | ||||
 By microscopy | 43/811 (5%)a | 35/740 (5%)b | 0.643 | 0.89 (0.54–1.44) |
 By PCR | 183/811 (23%) | 135/740 (18%) | 0.038* | 0.77 (0.59–0.99)* |
 By either test | 192/811 (24%) | 142/740 (19%) | 0.035* | 0.77 (0.59–0.98)* |
 Median parasitaemia/µL (IQR) (microscopy) | 112 (48–1000) | 80 (16–1080) | 0.832 |  |
 Median 18S copies/µL (IQR) (qPCR) (n baseline = 115, endpoint = 74) | 192.2 (60.6–605.2) | 177.7 (72.7–1535.0) | 0.719 |  |
Gametocyte prevalence | ||||
 By microscopy | 9/811 (1.1%) | 14/740 (1.9%) | 0.215 | 1.72 (0.69–4.53) |
 By pvs25 | 49/744 (7%) | 39/704 (5%) | 0.442 | 0.83 (0.52–1.31) |
 By either test | 49/744 (7%) | 39/704 (5%) | 0.442 | 0.83 (0.52–1.31) |
Gametocyte density (per μL) | ||||
 By microscopy (median) (IQR) | 160 (28–200) | 64 (32–170) | 0.516 |  |
 By pvs25 (geometric mean) (95%CI) | 56.4 (23.8–134.0) | 65.6 (26.5–162.2) | 0.810 | 0.9 (0.2–3.0) |